Our results indicated that curcumin prevented the translocation of gut-derived endotoxin LPS by reducing intestinal permeability and then lowered the ligand availability of TLR4, which also support that the anti-inflammatory and anti-NAFLD activities of curcumin occur along the gut-liver axis. Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.